Infante-Fernández C, González-Mondragón A, Pérez-Rojas DO, Atoche-Diéguez C, Arenas R, Ilizauturri FI

Language: Spanish
References: 23
Page: 32-39
PDF size: 273.49 Kb.

ABSTRACT

Leprosy is a chronic infectious disease affecting skin and peripheral nervous system. It is an important public health problem and has a wide spectrum of clinical manifestations. In this paper we report two leprosy cases studied at Centro Dermatológico de Yucatán, Mexico. A 62-year-old male with lepromatous leprosy and a 52-year-old male with borderline leprosy. In both cases Mycobacterium lepromatosis was identified by PCR.

REFERENCES

1. Aarão TL, De Sousa JR, Falcão ASC, Falcão LFM y Quaresma JAS, Nerve growth factor and pathogenesis of leprosy: review and update, Frontiers in Immunology 2018; 9: 1-8. doi.org/10.3389/fimmu.2018.00939.

2. Silva CAM y Belisle JT, Host lipid mediators in leprosy: the hypothesized contributions to pathogenesis, Frontiers in Immunology 2018; 9. doi.org/10.3389/fimmu.2018.00134.

3. De Andrade KVF, Nery JS, Pescarini JM, Ramond A, De Souza Teles Santos CA, Ichihara MY, Penna MLF, Brickley EB, Rodrigues LC, Smeeth L, Barreto ML, Martins Pereira S y Penna GO, Geographic and socioeconomic factors associated with leprosy treatment default: an analysis from the 100 million Brazilian cohort, plos Neglected Tropical Diseases 2019; 13(9). doi.org/10.1371/journal.pntd.0007714.

4. Pawar M y Zawar V, Mid-borderline leprosy masquerading as an overlap syndrome, Rheumatology (Reino Unido) 2018; 57(9): 1686-88. doi. org/10.1093/rheumatology/key125.

5. Pandhi D y Chhabra N, New insights in the pathogenesis of type 1 and type 2 lepra reaction, Indian J Dermatol Venereol Leprol 2013; 79:739-49.

6. Oo YM, Páez A y Brown R, Leprosy: a rare case of infectious peripheral neuropathy in the United States, idcases 2020; 20: e00765. doi. org/10.1016/j.idcr.2020.e00765.

7. Fischer M, Leprosy: an overview of clinical features, diagnosis, and treatment jddg-Journal of the German Society of Dermatology 2017; 15(8):801-27. doi.org/10.1111/ddg.13301.

8. Grzybowski A, Sak J, Suchodolska E y Virmond M, Lepra: various etiologies from miasma to bacteriology and genetics, Clinics in Dermatology 2015; 33(1): 3-7. doi.org/10.1016/j.clindermatol.2014.07.012.

9. World Health Organization, Global leprosy update 2015, Weekly Epidemiological Record 2016; 91:405-20.

10. Kaur G y Kaur J, Multifaceted role of lipids in Mycobacterium leprae, Future Microbiology 2017; 12(4):315.35. doi.org/10.2217/fmb-2016-0173.

11. Arenas R, Lepra. En Arenas R, Dermatología. Atlas, diagnóstico y tratamiento, 6ª ed., México, Mc Graw-Hill, 2015, pp. 406-20.

12. Torres-Guerrero E, Vargas-Martínez F, Atoche-Diéguez C, Arrazola J y Arenas Guzmán R, Lepra. Clasificación y cuadro clínico, Dermatol Rev Mex 2012; 56(1):47-54.

13. Peniche A y Saúl A, Dermatosis bacterianas. En Saúl A, Lecciones de dermatología, 16ª ed., México, Mc Graw-Hill, 2015, pp. 56-90.

14. Reibel F, Cambau E y Aubry A, Update on the epidemiology, diagnosis, and treatment of leprosy, Med Mal Infect 2015; 45(9):383-93. doi: 10.1016/j.medmal.2015.09.002.

15. Milena-Montes A, Orozco B y Gaviria M, Lepra dimorfa en estado reaccional tipo 1 y 2, Rev Asoc Col Dermatol 2009; 17(1):51-3.

16. Fleta-Zaragozano J, Lepra: aspectos clínicos y tratamiento, Med Integral 2001; 38(7):309-14.

17. Morfín-Maciel B y Jiménez Martínez M, Evaluación inmunológica durante el tratamiento de un caso de lepra dimorfa lepromatosa, Rev Alergia Mex 2016; 63(4):413-9. doi: 10.29262/ram.v63i4.170.

18. Gunawan H, Utami F, Aji Achdiat P, Avriyanti E, Hindritiani R y Suwarsa O, A unique case of borderline lepromatous leprosy with psoriasis-like lesions t all over the body and mycosis fungoides-like lesions on the face, J Clin Tuberc Other Mycobact Dis 2019; 17:100134.

19. Vora RV, Kota RK y Pariath AK, Leprosy: a mimicker of psoriasis, J Clin Diagn Res 2015; 9(9):1-2.

20. Re Domínguez ML, Di Martino Ortiz B y Rodríguez Masi M, Pápulas umbilicadas en un varón adulto joven: ¿cuál es su diagnóstico?, Piel (Barcelona) 2017; 32(1):34-9.

21. Ramos e Silva M y Bessa Rebello PF, Leprosy: recognition and treatment, Am J Clin Dermatol 2001; 2(4):203-11.

22. Concha RM, Cossío TL, Salazar SI, Fich SF, Pérez CC y González BS, Enfermedad de Hansen: revisión a propósito de un caso, Rev Chil Infect 2008; 25(1):64-9.

23. James WD, Elston DM, Treat JR, Rosenbach MA y Neuhaus IM, Hansen Disease. En James WD, Elston DM, Treat JR, Rosenbach MA y Neuhaus IM, Andrews’ diseases of the skin: clinical dermatology, 13ª ed., Nueva York, Elsevier, 2019, pp. 336-46.e1.